Botulinum toxin in the treatment of dystonias - A hospital based study

Journal of Association of Physicians of India

Volumn 51, Issue MAY, 2003, Pages 447-453

  Gupta, Meena ^a   Singh, G ^a   Khwaja, Geeta ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; DYSTONIA; FEMALE; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; DYSTONIC DISORDERS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1542756463     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jancovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
2. Tsui JKC, Bhatt M, Calne S, Calne DB. Botulinum toxin in the treatment of Writer's cramp: a double blind study. Neurology 1993;43:183-5.
3. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol 1992;239:5-8.
4. Jancovic J. Blepharospasm and oromandibular-laryngealcervical dystonia: A controlled trial of Botulinum A Toxin therapy. In Eds. Stanley Fahn et al. Advances in Neurology Raven Press, New York, dystonia 2. 1988;50:583-91.
5. Jancovic J. Botulinum toxin in the treatment of dystonia and other disorders. In Current Neurology Mosby Year Book Inc. 1994;14:207-29.
6. Brin MF, et al. Localized injections of Botulinum toxin for the treatment of focal dystonia and hemifacial spasm. In Eds. Stanley Fahn et al. Advances in Neurology Raven Press New York, dystonia 2. 1988;50:599-608.
7. Blackie JD, Lees AJ. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1990;53:640-3.
8. Comella CL, Jancovic J, Brin MF. Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology 2000;55 (Suppl 5):S15-S21.
9. Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992;42:878-82.
10. Brans JW, de Boer IP, Aramideh M, Ongerboer de Visser BW, Speelman JD. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 1995;242:529-34.
11. Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, Aminoff MJ. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 1991;29:370-6.
12. Bhaumik S, Behari M. Botulinum toxin A - Injection for cervical dystonia. JAPI 1999;47:267-70.
13. Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988;51:767-72.
14. Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1988;64:751-7.
15. Jancovic J, Schwartz KS. Clinical correlates of response to botulinum toxin injections. Arch Neurol 1991;48:1253-6.
16. Goschel H, Wohlfarth K, Frevert J, Dengler R, Bigalke H. Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies - therapeutic consequences. Exp Neurol 1997;147:96-102.